These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33668494)

  • 1. Improving Familial Hypercholesterolemia Index Case Detection: Sequential Active Screening from Centralized Analytical Data.
    Sabatel-Pérez F; Sánchez-Prieto J; Becerra-Muñoz VM; Alonso-Briales JH; Mata P; Rodríguez-Padial L
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33668494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile.
    Scicali R; Di Pino A; Platania R; Purrazzo G; Ferrara V; Giannone A; Urbano F; Filippello A; Rapisarda V; Farruggia E; Piro S; Rabuazzo AM; Purrello F
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):35-43. PubMed ID: 28958694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
    Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China.
    Jin W; Zhang Q; Wang B; Pan L; Qin H; Yang D; Zhou X; Du Y; Lin L; Kutryk MJ
    BMC Med Genet; 2019 Nov; 20(1):173. PubMed ID: 31706281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Hypercholesterolemia in Premature Acute Coronary Syndrome. Insights from CholeSTEMI Registry.
    Lorca R; Aparicio A; Cuesta-Llavona E; Pascual I; Junco A; Hevia S; Villazón F; Hernandez-Vaquero D; Rodríguez Reguero JJ; Moris C; Coto E; Gómez J; Avanzas P
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33137929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis.
    Chubykina UV; Ezhov MV; Afanasieva OI; Klesareva EA; Pokrovsky SN
    Diseases; 2022 Jan; 10(1):. PubMed ID: 35225859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study.
    Kullo IJ; Bailey KR
    J Pers Med; 2018 Aug; 8(3):. PubMed ID: 30142941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry.
    Vaseghi G; Taheri M; Heshmat-Ghahdarijani K; Rayati M; Zarfeshani S; Pourmoghaddas A; Khosravi A; Zarepour E; Keshavarzrad P; Arabi S; Azizi M; Haghjooy Javanmard S; Najafian J; Sarrafzadegan N
    J Lipids; 2021; 2021():9913969. PubMed ID: 34221513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
    Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
    Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified algorithm with lipoprotein(a) added for diagnosis of familial hypercholesterolemia.
    Sun D; Cao YX; Li S; Guo YL; Wu NQ; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    Clin Cardiol; 2019 Oct; 42(10):988-994. PubMed ID: 31436336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland.
    Pajak A; Szafraniec K; Polak M; Drygas W; Piotrowski W; Zdrojewski T; Jankowski P
    Arch Med Sci; 2016 Aug; 12(4):687-96. PubMed ID: 27478447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry.
    Truong TH; Do DL; Kim NT; Nguyen MT; Le TT; Le HA
    Front Genet; 2020; 11():914. PubMed ID: 32922439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the actual epidemiology of familial hypercholesterolemia in Italy? Evidence from a National Primary Care Database.
    Guglielmi V; Bellia A; Pecchioli S; Medea G; Parretti D; Lauro D; Sbraccia P; Federici M; Cricelli I; Cricelli C; Lapi F
    Int J Cardiol; 2016 Nov; 223():701-705. PubMed ID: 27568993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction.
    Cui Y; Li S; Zhang F; Song J; Lee C; Wu M; Chen H
    Clin Cardiol; 2019 Mar; 42(3):385-390. PubMed ID: 30637778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.
    Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of familial hypercholesterolemia in patients from a general practice database.
    Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
    Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
    De Luca L; Arca M; Temporelli PL; Colivicchi F; Gonzini L; Lucci D; Bosco B; Callerame M; Lettica GV; Di Lenarda A; Gulizia MM;
    Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.